The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats-Reference-Cited by-同舟云学术

The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats

Published:2021-06 Issue: Volume:275 Page:119334
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Gonzaga-Costa Karoline,Roque Cássia Rodrigues,Vasconcelos-Silva Alfredo Augusto,Sousa-Brito Hellida Larissa,Martins Conceição Silva,Caetano-Souza Marta Maria,Duarte Glória Pinto,da Silva Joyce Kelly Rosário,Borges Rosivaldo Santos,dos Santos Armênio Aguiar,Magalhães Pedro Jorge Caldas,Lahlou Saad

Funder

Fapespa

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference52 articles.

1. Primary pulmonary hypertension;Peacock;Thorax,1999

2. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides;Steiner;Curr. Opin. Pharmacol.,2005

3. Updated treatment algorithm of pulmonary arterial hypertension;Galiè;J. Am. Coll. Cardiol.,2013

4. Cellular and molecular basis of pulmonary arterial hypertension;Morrell;J. Am. Coll. Cardiol.,2009

5. Nitric oxide activates guanylate cyclase and increases guanosine 39:59-cyclic monophosphate levels in various tissue preparations;Arnold;Proc. Natl. Acad. Sci. U. S. A.,1977

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm;International Journal of Molecular Sciences;2023-05-25

2. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies;American Journal of Physiology-Heart and Circulatory Physiology;2022-05-01